Anivance AI Corporation
Update：2026/02/12
Industries
Main Industry
Health Care
Founded Year
2024
Unified Business No.
95464296
Status
Active
Number of Employees
20
Total Paid-in
Capital
26,130,000 (NT$)
Location of Company
Taiwan
, Hsinchu County
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, MOE. Exit status refers to various situations, including emerging stock exchanges (e.g., potential exits), mergers and acquisitions (M&A), and IPOs. The overseas development countries are collected through information provided by startups themselves and the information filled in when registering for matchmaking events. Therefore, the information cannot be updated in real time. If you wish to make corrections, please email findit.tier@gmail.com. Thank you.
Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person. Please do not contact this platform for company inquiries.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Anivance AI is transforming biomedical research by integrating organ-on-a-chip technology with human data-driven AI. Its platform combines human organ chips and advanced computational modeling to create digital twins, providing an alternative to traditional animal testing. By using patient-derived cells to build micro-organs, the system enables highly personalized simulation of drug responses. This approach improves predictive accuracy, shortens drug development timelines, and supports more ethical, data-driven research. By bridging biology and artificial intelligence, Anivance AI is positioning itself as a next-generation medical testing platform for precision medicine and pharmaceutical innovation.
